Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis - PubMed
- ️Invalid Date
Neutralizing TNF-alpha activity modulates T-cell phenotype and function in experimental autoimmune uveoretinitis
A D Dick et al. J Autoimmun. 1998 Jun.
Abstract
Inhibiting TNF-alpha activity prevents tissue destruction without inhibiting retinal T cell infiltration in experimental autoimmune uveoretinitis (EAU) in Lewis rats. To further determine the role of TNF-alpha in autoimmune uveitis we characterized T cells isolated from retinae after treatment with a TNF-alpha antagonist. TNF-alpha activity was neutralized in vivo with a p55 TNF-alpha receptor-Ig fusion protein (sTNFr-Ig), administered 8 and 10 days after induction of EAU with heterologous retinal antigens. Retinal T-cell phenotype expression was examined by flow cytometry with respect to OX22 status (CD45RBlow or CD45RBhigh), activation (OX40 and CD25 expression) and rate of T-cell apoptosis (Annexin V+PI- expression). Lymphocyte reactivity was assessed by proliferation responses and cytokine production to retinal antigens. Despite greater than 40% of CD4+ T cells being activated at the height of disease, the proportion of OX22low expression was reduced and T cells exhibited reduced IFN-gamma and elevated IL-4 production. Retinal T cells maintained antigen-specific proliferation and demonstrated a low apoptotic rate. Although in both animal groups, comparable numbers of T cells were isolated, neutralizing TNF activity suppressed Th1 effector mechanisms protecting against target organ damage.
Similar articles
-
Dick AD, McMenamin PG, Körner H, Scallon BJ, Ghrayeb J, Forrester JV, Sedgwick JD. Dick AD, et al. Eur J Immunol. 1996 May;26(5):1018-25. doi: 10.1002/eji.1830260510. Eur J Immunol. 1996. PMID: 8647162
-
Recombinant IL-4 aggravates experimental autoimmune uveoretinitis in rats.
Ramanathan S, de Kozak Y, Saoudi A, Goureau O, Van der Meide PH, Druet P, Bellon B. Ramanathan S, et al. J Immunol. 1996 Sep 1;157(5):2209-15. J Immunol. 1996. PMID: 8757348
-
Laliotou B, Duncan L, Dick AD. Laliotou B, et al. J Autoimmun. 1999 May;12(3):145-55. doi: 10.1006/jaut.1998.0269. J Autoimmun. 1999. PMID: 10222024
-
The role of tumour necrosis factor (TNF-alpha) in experimental autoimmune uveoretinitis (EAU).
Dick AD, Forrester JV, Liversidge J, Cope AP. Dick AD, et al. Prog Retin Eye Res. 2004 Nov;23(6):617-37. doi: 10.1016/j.preteyeres.2004.06.005. Prog Retin Eye Res. 2004. PMID: 15388077 Review.
-
Mizuguchi J, Takeuchi M, Usui M. Mizuguchi J, et al. Arch Immunol Ther Exp (Warsz). 2002;50(4):243-54. Arch Immunol Ther Exp (Warsz). 2002. PMID: 12371620 Review.
Cited by
-
Systemic therapies for inflammatory eye disease: past, present and future.
Denniston AK, Dick AD. Denniston AK, et al. BMC Ophthalmol. 2013 Apr 24;13:18. doi: 10.1186/1471-2415-13-18. BMC Ophthalmol. 2013. PMID: 23617902 Free PMC article. Review.
-
Tumor necrosis factor (TNF) inhibitors for juvenile idiopathic arthritis-associated uveitis.
Renton WD, Jung J, Palestine AG. Renton WD, et al. Cochrane Database Syst Rev. 2022 Oct 14;10(10):CD013818. doi: 10.1002/14651858.CD013818.pub2. Cochrane Database Syst Rev. 2022. PMID: 36239193 Free PMC article. Review.
-
Pepple KL, Wilson L, Van Gelder RN, Kovaleva M, Ubah OC, Steven J, Barelle CJ, Porter A. Pepple KL, et al. Transl Vis Sci Technol. 2019 Sep 18;8(5):11. doi: 10.1167/tvst.8.5.11. eCollection 2019 Sep. Transl Vis Sci Technol. 2019. PMID: 31588375 Free PMC article.
-
Interplay between innate and adaptive immunity in the development of non-infectious uveitis.
Willermain F, Rosenbaum JT, Bodaghi B, Rosenzweig HL, Childers S, Behrend T, Wildner G, Dick AD. Willermain F, et al. Prog Retin Eye Res. 2012 Mar;31(2):182-94. doi: 10.1016/j.preteyeres.2011.11.004. Epub 2011 Nov 22. Prog Retin Eye Res. 2012. PMID: 22120610 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous